{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:05:58Z","timestamp":1784185558582,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jiac.2026.103016","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:45:48Z","timestamp":1781541948000},"page":"103016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Continuation of anti-tuberculosis therapy after Clostridioides difficile infection: a retrospective cohort study"],"prefix":"10.1016","volume":"32","author":[{"given":"Katsuhiro","family":"Itogawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Narumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2935-5553","authenticated-orcid":false,"given":"Keita","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2248-3376","authenticated-orcid":false,"given":"Takafumi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurina","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiteru","family":"Morio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8648-2191","authenticated-orcid":false,"given":"Atsuhisa","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8322-5878","authenticated-orcid":false,"given":"Yuka","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.103016_bib1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.anaerobe.2018.01.011","article-title":"Clostridioides (Clostridium) difficile infection in hospitalized patients with antibiotic-associated diarrhea: a systematic review and meta-analysis","volume":"50","author":"Nasiri","year":"2018","journal-title":"Anaerobe"},{"key":"10.1016\/j.jiac.2026.103016_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad413","article-title":"Comparison of different antibiotics and the risk for community-associated Clostridioides difficile infection: a case-control study","volume":"10","author":"Miller","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2026.103016_bib3","series-title":"Antimicrobial prescribing","year":"2021"},{"key":"10.1016\/j.jiac.2026.103016_bib4","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1365-2958.2006.05467.x","article-title":"Mechanisms of action of isoniazid","volume":"62","author":"Timmins","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jiac.2026.103016_bib5","doi-asserted-by":"crossref","first-page":"e02213","DOI":"10.1128\/mBio.02213-16","article-title":"The antituberculosis drug ethambutol selectively blocks apical growth in CMN group bacteria","volume":"8","author":"Schubert","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.jiac.2026.103016_bib6","first-page":"6","article-title":"The curious characteristics of pyrazinamide: a review","volume":"7","author":"Zhang","year":"2003","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2026.103016_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/imr.12563","article-title":"The intestinal microbiota: antibiotics, colonization resistance, and enteric pathogens","volume":"279","author":"Kim","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jiac.2026.103016_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1086\/596315","article-title":"High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital","volume":"48","author":"Curry","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.103016_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MAJ.0b013e31819f1eec","article-title":"Rifampin-associated pseudomembranous colitis","volume":"338","author":"Chen","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jiac.2026.103016_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MCG.0b013e31802dfaf7","article-title":"Clinical aspects of rifampicin-associated pseudomembranous colitis","volume":"41","author":"Jung","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jiac.2026.103016_bib11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10096-013-1845-5","article-title":"Emergence of Clostridium difficile infection in tuberculosis patients due to a highly rifampicin-resistant PCR ribotype 046 clone in Poland","volume":"32","author":"Obuch-Woszczaty\u0144ski","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2026.103016_bib12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/ciw566","article-title":"Executive summary: official American thoracic society\/centers for disease control and prevention\/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.103016_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jiac.2021.12.031","article-title":"The feasibility of rifampicin Re-administration in patients with tuberculosis and Clostridioides difficile infection","volume":"28","author":"Kurahara","year":"2022","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103016_bib14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5009\/gnl14435","article-title":"Incidence and clinical outcomes of Clostridium difficile infection after treatment with tuberculosis medication","volume":"10","author":"Lee","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.jiac.2026.103016_bib15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.103016_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2026.103016_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx171","article-title":"Risk factors for community-associated Clostridium difficile infection in adults: a case-control study","volume":"4","author":"Guh","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2026.103016_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cmi.2017.07.012","article-title":"Susceptibilities of clinical Clostridium difficile isolates to antimicrobials: a systematic review and meta-analysis of studies since 1970","volume":"24","author":"Khanafer","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2026.103016_bib19","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/jac\/dkr377","article-title":"A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection","volume":"66","author":"Garey","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2026.103016_bib20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1017\/ice.2014.88","article-title":"Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis","volume":"36","author":"Deshpande","year":"2015","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26001145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26001145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:33:04Z","timestamp":1784183584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26001145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1341321X26001145"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103016","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuation of anti-tuberculosis therapy after Clostridioides difficile infection: a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103016"}}